Advertisement
This campaign follows the recent refusal by Trinity Biotech directors tohonor an earlier request by a group of ADR holders for the calling of aspecial meeting of shareholders to consider the removal and replacement of thecompany's current directors. The directors' rejection of the request wasbased on their determination that ADRs have fewer rights under Irish law thanthe ordinary shares into which they may be converted. The directors alsorefused to take alternative steps proposed by the requesting group to convenethe meeting.
Advertisement
Commenting on the campaign, Tom Reidy stated, "The directors' blatantdisregard for our basic rights as owners of the company has only heightenedour resolve to impose accountability on company management. We are calling onall ADR holders who believe that a board change is in order to join with us inconverting ADRs to ordinary shares. While none of us should be forced to takethis unnecessary step, we believe this is the only way we can protect ourinvestment."
Important Next Steps: ADR holders who would like assistance in convertingtheir ADRs should contact Mr. Reidy at [email protected] or (816) 260-8476.
SOURCE KC Investor Group
